COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
S Colafrancesco, C Alessandri, F Conti, R Priori - Autoimmunity reviews, 2020 - Elsevier
The severe form of COVID-19 share several clinical and laboratory features with four
entities gathered under the term “hyperferritinemic syndromes” and including macrophage …
entities gathered under the term “hyperferritinemic syndromes” and including macrophage …
Switching tumour necrosis factor α antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period
F Conti, F Ceccarelli, E Marocchi, L Magrini… - Annals of the …, 2007 - ard.bmj.com
Objective: To evaluate the clinical response after switching from one tumour necrosis factor (TNF)α
antagonist to another in patients with ankylosing spondylitis (AS) and psoriatic …
antagonist to another in patients with ankylosing spondylitis (AS) and psoriatic …
Smoke and autoimmunity: The fire behind the disease
…, S Gertel, A Watad, MJ Segel, F Ceccarelli, F Conti… - Autoimmunity …, 2016 - Elsevier
The association between smoke habit and autoimmunity has been hypothesized a long time
ago. Smoke has been found to play a pathogenic role in certain autoimmune disease as it …
ago. Smoke has been found to play a pathogenic role in certain autoimmune disease as it …
Anti–β2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts
…, R Misasi, C Alessandri, F Conti… - Arthritis & …, 2007 - Wiley Online Library
Objective To investigate the association of β 2 ‐glycoprotein I (β 2 GPI) with lipid rafts in
monocytic cells and to evaluate the proinflammatory and procoagulant effects of anti‐β 2 GPI …
monocytic cells and to evaluate the proinflammatory and procoagulant effects of anti‐β 2 GPI …
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: A role for scintigraphy with 99mTc‐infliximab
F Conti, R Priori, MS Chimenti, G Coari… - Arthritis & …, 2005 - Wiley Online Library
Positive experiences with intraarticular infliximab have been reported in patients with rheumatoid
arthritis, ankylosing spondylitis, and Behçet's disease. We used intraarticular infliximab …
arthritis, ankylosing spondylitis, and Behçet's disease. We used intraarticular infliximab …
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort
F Conti, F Ceccarelli, C Perricone, I Leccese… - Lupus, 2016 - journals.sagepub.com
Objectives Literature data suggest a significantly higher mortality in patients affected by systemic
lupus erythematosus (SLE) developing chronic damage. Therefore, damage prevention …
lupus erythematosus (SLE) developing chronic damage. Therefore, damage prevention …
14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome
…, I Rodríguez-Pintó, S Colafrancesco, F Conti… - Autoimmunity …, 2014 - Elsevier
The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the
occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives …
occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives …
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus
…, CA Scire, S Bombardieri, L Caniatti, F Conti… - …, 2015 - academic.oup.com
Objective. The aim of this study was to develop and validate an algorithm to assist the attribution
of neuropsychiatric (NP) events to underlying disease in SLE patients. Methods. Phase …
of neuropsychiatric (NP) events to underlying disease in SLE patients. Methods. Phase …
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
…, M Benucci, MA Cimmino, V Riccieri, F Conti… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies
F Conti, C Alessandri, D Bompane, M Bombardieri… - Arthritis Res Ther, 2004 - Springer
This study was performed to determine the correlation between psychiatric manifestations
and several autoantibodies that might participate in the pathogenesis of psychiatric disorders …
and several autoantibodies that might participate in the pathogenesis of psychiatric disorders …